Medtronic (MDT) Tops Q3 EPS by 2c; offers guidance
Tweet
Share
E-mail
Get Alerts MDT Hot Sheet
Price: $91.27 +0.76%
EPS Growth %: +10.3%
Financial Fact:
Research and development expense: 373M
Today's EPS Names:
SVBT, ZEO, OTLK, More
EPS Growth %: +10.3%
Financial Fact:
Research and development expense: 373M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Medtronic (NYSE: MDT) reported Q3 EPS of $1.36, $0.02 better than the analyst estimate of $1.34. Revenue for the quarter came in at $9 billion versus the consensus estimate of $8.91 billion.
GUIDANCE:
Medtronic sees FY2026 EPS of $5.62-$5.66, versus the consensus of $5.65.
For earnings history and earnings-related data on Medtronic (MDT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
